Q9GZX3 (CHST6_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 100.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Carbohydrate sulfotransferase 6 EC=2.8.2.- Alternative name(s): Corneal N-acetylglucosamine-6-O-sulfotransferase Short name=C-GlcNAc6ST Short name=hCGn6ST Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-beta Short name=GST4-beta N-acetylglucosamine 6-O-sulfotransferase 5 Short name=GlcNAc6ST-5 Short name=Gn6st-5 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 395 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the transfer of sulfate to position 6 of non-reducing N-acetylglucosamine (GlcNAc) residues of keratan. Mediates sulfation of keratan in cornea. Keratan sulfate plays a central role in maintaining corneal transparency. Acts on the non-reducing terminal GlcNAc of short and long carbohydrate substrates that have poly-N-acetyllactosamine structures. Ref.5 Ref.6 |
| Subcellular location | Golgi apparatus membrane; Single-pass type II membrane protein By similarity. |
| Tissue specificity | Expressed in cornea. Mainly expressed in brain. Also expressed in spinal cord and trachea. Ref.1 Ref.2 Ref.5 |
| Involvement in disease | Macular dystrophy, corneal, 1 (MCDC1) [MIM:217800]: An ocular disease characterized by bilateral, progressive corneal opacification, and reduced corneal sensitivity. Onset occurs in the first decade, usually between ages 5 and 9. Painful attacks with photophobia, foreign body sensations, and recurrent erosions occur in most patients. The disease is due to deposition of an unsulfated keratan sulfate both within the intracellular space (within the keratocytes and endothelial cells) and in the extracellular corneal stroma. Macular corneal dystrophy is divided into the clinically indistinguishable types I, IA, and II based on analysis of the normally sulfated, or antigenic, keratan sulfate levels in serum and immunohistochemical evaluation of the cornea. Patients with types I and IA macular corneal dystrophy have undetectable serum levels of antigenic keratan sulfate, whereas those with type II macular corneal dystrophy have normal or low levels, depending on the population examined. |
| Sequence similarities | Belongs to the sulfotransferase 1 family. Gal/GlcNAc/GalNAc subfamily. |
| Caution | Ref.9 reported a Gly-204 variant, however according to their results reported in figure 1, it is a Gln-204 variant. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Carbohydrate metabolism |
| Cellular component | Golgi apparatus Membrane |
| Coding sequence diversity | Polymorphism |
| Disease | Corneal dystrophy Disease mutation |
| Domain | Signal-anchor Transmembrane Transmembrane helix |
| Molecular function | Transferase |
| PTM | Glycoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | N-acetylglucosamine metabolic process Inferred from direct assay Ref.5. Source: UniProtKB carbohydrate metabolic processTraceable author statement. Source: Reactome keratan sulfate biosynthetic processInferred from direct assay PubMed 11278593. Source: UniProtKB |
| Cellular_component | Golgi membrane Traceable author statement. Source: Reactome integral to membraneInferred from electronic annotation. Source: UniProtKB-KW |
| Molecular_function | N-acetylglucosamine 6-O-sulfotransferase activity Inferred from direct assay PubMed 11278593Ref.5. Source: UniProtKB |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 395 | 395 | Carbohydrate sulfotransferase 6 | PRO_0000085197 | |||||
Regions | |||||||||
| Topological domain | 1 – 5 | 5 | Cytoplasmic Potential | ||||||
| Transmembrane | 6 – 26 | 21 | Helical; Signal-anchor for type II membrane protein; Potential | ||||||
| Topological domain | 27 – 395 | 369 | Lumenal Potential | ||||||
| Nucleotide binding | 49 – 55 | 7 | PAPS By similarity | ||||||
| Nucleotide binding | 202 – 210 | 9 | PAPS By similarity | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 116 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 229 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 305 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 328 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Natural variant | 15 | 1 | L → P in MCDC1. Ref.9 | VAR_021417 | |||||
| Natural variant | 22 | 1 | L → R in MCDC1. Ref.13 | VAR_021418 | |||||
| Natural variant | 31 | 1 | P → S in MCDC1. Ref.8 | VAR_021419 | |||||
| Natural variant | 42 | 1 | H → Y in MCDC1. Ref.13 | VAR_021420 | |||||
| Natural variant | 50 | 1 | R → C in MCDC1; abolishes ability to sulfate keratan. Ref.1 Ref.6 Corresponds to variant rs28937877 [ dbSNP | Ensembl ]. | VAR_021421 | |||||
| Natural variant | 51 | 1 | S → L in MCDC1. Ref.12 Ref.16 | VAR_021422 | |||||
| Natural variant | 52 | 1 | G → D in MCDC1. Ref.14 | VAR_021423 | |||||
| Natural variant | 53 | 1 | S → L in MCDC1. Ref.13 Ref.14 | VAR_021424 | |||||
| Natural variant | 59 | 1 | L → P in MCDC1. Ref.12 | VAR_021425 | |||||
| Natural variant | 61 | 1 | N → T in MCDC1. Ref.9 | VAR_021426 | |||||
| Natural variant | 66 | 1 | V → L in MCDC1. Ref.12 | VAR_021427 | |||||
| Natural variant | 68 | 1 | Y → H in MCDC1. Ref.9 | VAR_021428 | |||||
| Natural variant | 70 | 1 | M → L in MCDC1. Ref.9 | VAR_021429 | |||||
| Natural variant | 72 | 1 | P → S in MCDC1. Ref.8 Ref.16 | VAR_021430 | |||||
| Natural variant | 76 | 1 | V → M in MCDC1. Ref.12 | VAR_021431 | |||||
| Natural variant | 93 | 1 | R → H in MCDC1. Ref.13 | VAR_021432 | |||||
| Natural variant | 97 | 1 | R → P in MCDC1. Ref.13 | VAR_021433 | |||||
| Natural variant | 98 | 1 | S → W in MCDC1. Ref.14 | VAR_021434 | |||||
| Natural variant | 102 | 1 | C → G in MCDC1. Ref.9 Ref.15 Ref.16 | VAR_021435 | |||||
| Natural variant | 102 | 1 | C → Y in MCDC1. Ref.13 | VAR_021436 | |||||
| Natural variant | 104 | 1 | M → V in MCDC1. Ref.16 | VAR_021437 | |||||
| Natural variant | 107 | 1 | F → S in MCDC1. Ref.8 Ref.14 | VAR_021438 | |||||
| Natural variant | 110 | 1 | Y → C in MCDC1. Ref.16 | VAR_021439 | |||||
| Natural variant | 121 | 1 | F → L in MCDC1. Ref.14 | VAR_021440 | |||||
| Natural variant | 122 | 1 | Q → P in MCDC1. Ref.16 | VAR_021441 | |||||
| Natural variant | 127 | 1 | R → C in MCDC1. Ref.13 | VAR_021442 | |||||
| Natural variant | 128 | 1 | A → V in MCDC1. Ref.7 | VAR_021443 | |||||
| Natural variant | 131 | 1 | S → P in MCDC1. Ref.9 | VAR_021444 | |||||
| Natural variant | 152 | 1 | L → P in MCDC1. Ref.9 | VAR_021445 | |||||
| Natural variant | 162 | 1 | R → G in MCDC1. Ref.15 | VAR_021446 | |||||
| Natural variant | 166 | 1 | R → P in MCDC1. Ref.7 Ref.9 | VAR_021447 | |||||
| Natural variant | 174 | 1 | K → R in MCDC1; abolishes ability to sulfate keratan. Ref.1 Ref.6 Corresponds to variant rs28937878 [ dbSNP | Ensembl ]. | VAR_021448 | |||||
| Natural variant | 177 | 1 | R → H in MCDC1. Ref.10 | VAR_021449 | |||||
| Natural variant | 198 | 1 | V → E in MCDC1. Ref.15 | VAR_021450 | |||||
| Natural variant | 200 | 1 | L → R in MCDC1. Ref.8 Ref.9 Ref.15 Ref.16 Ref.17 Corresponds to variant rs28937879 [ dbSNP | Ensembl ]. | VAR_021451 | |||||
| Natural variant | 202 | 1 | R → S in MCDC1. Ref.14 | VAR_021452 | |||||
| Natural variant | 203 | 1 | D → E in MCDC1; abolishes ability to sulfate keratan. Ref.1 Ref.6 Corresponds to variant rs28937878 [ dbSNP | Ensembl ]. | VAR_021453 | |||||
| Natural variant | 204 | 1 | P → Q in MCDC1. Ref.9 Ref.10 Ref.14 | VAR_021454 | |||||
| Natural variant | 205 | 1 | R → L in MCDC1. Ref.10 | VAR_021455 | |||||
| Natural variant | 205 | 1 | R → Q in MCDC1. Ref.13 | VAR_021456 | |||||
| Natural variant | 206 | 1 | A → T in MCDC1. Ref.13 | VAR_021457 | |||||
| Natural variant | 206 | 1 | A → V in MCDC1. Ref.8 | VAR_021458 | |||||
| Natural variant | 210 | 1 | S → F in MCDC1. Ref.14 | VAR_021459 | |||||
| Natural variant | 211 | 1 | R → Q in MCDC1. Ref.11 Ref.12 | VAR_021460 | |||||
| Natural variant | 211 | 1 | R → W in MCDC1; abolishes ability to sulfate keratan. Ref.1 Ref.6 Ref.10 | VAR_021461 | |||||
| Natural variant | 217 | 1 | A → T in MCDC1; abolishes ability to sulfate keratan. Ref.6 Ref.10 | VAR_021462 | |||||
| Natural variant | 221 | 1 | D → E in MCDC1. Ref.14 | VAR_021463 | |||||
| Natural variant | 221 | 1 | D → Y in MCDC1. Ref.14 | VAR_021464 | |||||
| Natural variant | 249 | 1 | H → P in MCDC1. Ref.13 | VAR_021465 | |||||
| Natural variant | 268 | 1 | Y → C in MCDC1. Ref.12 | VAR_021466 | |||||
| Natural variant | 274 | 1 | E → K in MCDC1; abolishes ability to sulfate keratan. Ref.1 Ref.6 Ref.13 | VAR_021467 | |||||
| Natural variant | 276 | 1 | L → P in MCDC1. Ref.16 Ref.17 | VAR_021468 | |||||
| Natural variant | 358 | 1 | Y → D in MCDC1. Ref.17 | VAR_021469 | |||||
| Natural variant | 369 | 1 | N → D. Corresponds to variant rs35036798 [ dbSNP | Ensembl ]. | VAR_033735 | |||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene." Akama T.O., Nishida K., Nakayama J., Watanabe H., Ozaki K., Nakamura T., Dota A., Kawasaki S., Inoue Y., Maeda N., Yamamoto S., Fujiwara T., Thonar E.J.-M.A., Shimomura Y., Kinoshita S., Tanigami A., Fukuda M.N. Nat. Genet. 26:237-241(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], TISSUE SPECIFICITY, VARIANTS MCDC1 CYS-50; ARG-174; GLU-203; TRP-211 AND LYS-274. |
| [2] | "Chromosomal localization and genomic organization for the galactose/ N-acetylgalactosamine/N-acetylglucosamine 6-O-sulfotransferase gene family." Hemmerich S., Lee J.K., Bhakta S., Bistrup A., Ruddle N.R., Rosen S.D. Glycobiology 11:75-87(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY. |
| [3] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Lung. |
| [5] | "Sulfation of endothelial mucin by corneal keratan N-acetylglucosamine 6-O-sulfotransferase (GST-4beta)." Bartes A., Bhakta S., Hemmerich S. Biochem. Biophys. Res. Commun. 282:928-933(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY. |
| [6] | "Enzymatic synthesis in vitro of the disulfated disaccharide unit of corneal keratan sulfate." Akama T.O., Misra A.K., Hindsgaul O., Fukuda M.N. J. Biol. Chem. 277:42505-42513(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBSTRATE SPECIFICITY, VARIANTS MCDC1 CYS-50; ARG-174; GLU-203; TRP-211; THR-217 AND LYS-274. |
| [7] | "Mutations in corneal carbohydrate sulfotransferase 6 gene (CHST6) cause macular corneal dystrophy in Iceland." Liu N.-P., Dew-Knight S., Rayner M., Jonasson F., Akama T.O., Fukuda M.N., Bao W., Gilbert J.R., Vance J.M., Klintworth G.K. Mol. Vis. 6:261-264(2000) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS MCDC1 VAL-128 AND PRO-166. |
| [8] | "Identification of novel mutations in the carbohydrate sulfotransferase gene (CHST6) causing macular corneal dystrophy." El-Ashry M.F., El-Aziz M.M., Wilkins S., Cheetham M.E., Wilkie S.E., Hardcastle A.J., Halford S., Bayoumi A.Y., Ficker L.A., Tuft S., Bhattacharya S.S., Ebenezer N.D. Invest. Ophthalmol. Vis. Sci. 43:377-382(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS MCDC1 SER-31; SER-72; SER-107; ARG-200 AND VAL-206. |
| [9] | "Truncating mutations in the carbohydrate sulfotransferase 6 gene (CHST6) result in macular corneal dystrophy." Niel F., Ellies P., Dighiero P., Soria J., Sabbagh C., San C., Renard G., Delpech M., Valleix S. Invest. Ophthalmol. Vis. Sci. 44:2949-2953(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS MCDC1 PRO-15; THR-61; HIS-68; LEU-70; GLY-102; PRO-131; PRO-152; PRO-166; ARG-200 AND GLN-204. |
| [10] | "Mutations in the CHST6 gene in patients with macular corneal dystrophy: immunohistochemical evidence of heterogeneity." Iida-Hasegawa N., Furuhata A., Hayatsu H., Murakami A., Fujiki K., Nakayasu K., Kanai A. Invest. Ophthalmol. Vis. Sci. 44:3272-3277(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS MCDC1 HIS-177; GLN-204; LEU-205; TRP-211 AND THR-217. |
| [11] | "Identification of novel mutations of the CHST6 gene in Vietnamese families affected with macular corneal dystrophy in two generations." Ha N.T., Chau H.M., Cung le X., Thanh T.K., Fujiki K., Murakami A., Hiratsuka Y., Hasegawa N., Kanai A. Cornea 22:508-511(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT MCDC1 GLN-211. |
| [12] | "Mutation analysis of the carbohydrate sulfotransferase gene in Vietnamese with macular corneal dystrophy." Ha N.T., Chau H.M., Cung le X., Thanh T.K., Fujiki K., Murakami A., Hiratsuka Y., Kanai A. Invest. Ophthalmol. Vis. Sci. 44:3310-3316(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS MCDC1 LEU-51; PRO-59; LEU-66; MET-76; GLN-211; GLN-211; CYS-268 AND CYS-268. |
| [13] | "Novel mutations in the CHST6 gene associated with macular corneal dystrophy in southern India." Warren J.F., Aldave A.J., Srinivasan M., Thonar E.J., Kumar A.B., Cevallos V., Whitcher J.P., Margolis T.P. Arch. Ophthalmol. 121:1608-1612(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS MCDC1 ARG-22; TYR-42; LEU-53; HIS-93; PRO-97; TYR-102; CYS-127; GLN-205; THR-206; PRO-249 AND LYS-274. |
| [14] | "Novel mutations of the carbohydrate sulfotransferase-6 (CHST6) gene causing macular corneal dystrophy in India." Sultana A., Sridhar M.S., Jagannathan A., Balasubramanian D., Kannabiran C., Klintworth G.K. Mol. Vis. 9:730-734(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS MCDC1 ASP-52; LEU-53; TRP-98; SER-107; LEU-121; SER-202; GLN-204; PHE-210; GLU-221 AND TYR-221. |
| [15] | "Novel mutations in the CHST6 gene causing macular corneal dystrophy." Abbruzzese C., Kuhn U., Molina F., Rama P., De Luca M. Clin. Genet. 65:120-125(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS MCDC1 GLY-102; GLY-162; GLU-198 AND ARG-200. |
| [16] | "Novel mutations in the carbohydrate sulfotransferase gene (CHST6) in American patients with macular corneal dystrophy." Aldave A.J., Yellore V.S., Thonar E.J., Udar N., Warren J.F., Yoon M.K., Cohen E.J., Rapuano C.J., Laibson P.R., Margolis T.P., Small K. Am. J. Ophthalmol. 137:465-473(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS MCDC1 LEU-51; SER-72; GLY-102; VAL-104; CYS-110; PRO-122; ARG-200 AND PRO-276. |
| [17] | "Novel CHST6 nonsense and missense mutations responsible for macular corneal dystrophy." El-Ashry M.F., Abd El-Aziz M.M., Shalaby O., Wilkins S., Poopalasundaram S., Cheetham M., Tuft S.J., Hardcastle A.J., Bhattacharya S.S., Ebenezer N.D. Am. J. Ophthalmol. 139:192-193(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS MCDC1 ARG-200; PRO-276 AND ASP-358. |
| + | Additional computationally mapped references. |
Web resources
| GGDB GlycoGene database |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF219990 mRNA. Translation: AAG26325.1. AF219991 Genomic DNA. Translation: AAG26327.1. AF280086 mRNA. Translation: AAG48244.1. CH471114 Genomic DNA. Translation: EAW95640.1. CH471114 Genomic DNA. Translation: EAW95641.1. BC074883 mRNA. Translation: AAH74883.1. BC074834 mRNA. Translation: AAH74834.1. |
| IPI | IPI00012402. |
| RefSeq | NP_067628.1. NM_021615.4. |
| UniGene | Hs.655622. |
3D structure databases | |
| ProteinModelPortal | Q9GZX3. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 9606.ENSP00000328983. |
PTM databases | |
| PhosphoSite | Q9GZX3. |
Polymorphism databases | |
| DMDM | 61212105. |
Proteomic databases | |
| PaxDb | Q9GZX3. |
| PRIDE | Q9GZX3. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000332272; ENSP00000328983; ENSG00000183196. ENST00000390664; ENSP00000375079; ENSG00000183196. |
| GeneID | 4166. |
| KEGG | hsa:4166. |
| UCSC | uc002fef.3. human. |
Organism-specific databases | |
| CTD | 4166. |
| GeneCards | GC16M075508. |
| HGNC | HGNC:6938. CHST6. |
| MIM | 217800. phenotype. 605294. gene. |
| neXtProt | NX_Q9GZX3. |
| Orphanet | 98969. Macular corneal dystrophy. |
| PharmGKB | PA26506. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG300333. |
| HOGENOM | HOG000261614. |
| HOVERGEN | HBG050949. |
| InParanoid | Q9GZX3. |
| KO | K09671. |
| OMA | FSWASST. |
| OrthoDB | EOG4RXZ09. |
Enzyme and pathway databases | |
| Reactome | REACT_111217. Metabolism. REACT_116125. Disease. |
Gene expression databases | |
| Bgee | Q9GZX3. |
| CleanEx | HS_CHST6. |
| Genevestigator | Q9GZX3. |
| GermOnline | ENSG00000183196. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR016469. Carbohydrate_sulfotransferase. IPR027417. P-loop_NTPase. IPR000863. Sulfotransferase_dom. [Graphical view] |
| Pfam | PF00685. Sulfotransfer_1. 1 hit. [Graphical view] |
| PIRSF | PIRSF005883. Carbohydrate_sulfotransferase. 1 hit. |
| SUPFAM | SSF52540. SSF52540. 1 hit. |
| ProtoNet | Search... |
Other | |
| ChiTaRS | CHST6. human. |
| GenomeRNAi | 4166. |
| NextBio | 16408. |
| SOURCE | Search... |
Entry information
| Entry name | CHST6_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9GZX3 Secondary accession number(s): D3DUK3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 16 Human chromosome 16: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
